India cancer-drug market to grow 16 percent annually; FL biotech show shows importance of industry in region;

 @FierceBiotech: Big Pharma tries to think like a biotech while reengineering R&D. Report | Follow @FierceBiotech

 @JohnCFierce: Big Pharma knows it has a huge development problem, but I don't buy the we'll-act-like-biotechs-from-now-on routine. | Follow @JohnCFierce

> India's cancer-drug market, valued at about $271 million, will grow 16 percent annually for the next five years, driven by increased demand for the latest tumor- fighting therapies, Datamonitor Group said. Report

> In recent years, more than 500 attendees and 60 vendors have filled tents on the grounds of Progress Corporate Park for BioFlorida's Celebration of Biotechnology, evidence of how far the industry has come and its importance to the economies of Florida and the region. Item

> ConjuGon, a Madison biotechnology company that is developing products for treating stubborn bacterial infections has raised $1.9 million of equity funding, according to a filing with the SEC. Story

> Millennium Partners is branching out into biotech in Burlingame. The preeminent builder of four-star hotels and $2 million downtown condos has submitted a plan to construct 700,000 square feet of biotech or office space on the 18-acre site of former drive-in movie theater at 350 Beach Road in Burlingame. Article

> When the searing heat gives way to monsoons, Suchitra Ella hopes her firm will have the licence for the commercial manufacture of H1N1 vaccine. Report

>  ARCA Biopharma received notification from the NASDAQ Stock Market that it has demonstrated compliance with the minimum stockholders' equity requirement is in compliance with all applicable requirements for continued listing on the NASDAQ Global Market. Release

> Beike Biotechnology Co and the Jiangsu government's China Medical City opened China's state-of-the-art stem cell storage and processing facility. The 20,000 square-meter Stem Cell Regenerative Medicine Industrial Project of National Bio-Industry Base houses China's first comprehensive regenerative medicine technology center and its largest international stem cell bank. Report

And Finally... A new discovery from Stanford researchers may pave the way for a deafness cure. Report

Suggested Articles

After delivering a "positive surprise" in December, Biogen is painting a fuller picture of its lupus drug.

A new CRISPR technique neutralizes SARS-CoV-2 by scrambling the virus' genetic code. It could prove useful for fighting other viruses, like influenza.

The deal, which follows a bidding war with AcelRx, gives Melinta another approved antibiotic and potentially complementary R&D expertise.